Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Drops By 81.0%

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant decline in short interest in March. As of March 13th, there was short interest totaling 8,449 shares, a decline of 81.0% from the February 26th total of 44,566 shares. Based on an average daily trading volume, of 3,935,254 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 3,935,254 shares, the days-to-cover ratio is presently 0.0 days.

CV Sciences Price Performance

OTCMKTS:CVSI traded up $0.00 during trading hours on Tuesday, hitting $0.04. The company’s stock had a trading volume of 382,660 shares, compared to its average volume of 1,217,137. CV Sciences has a 52-week low of $0.02 and a 52-week high of $0.10. The company has a current ratio of 1.07, a quick ratio of 0.21 and a debt-to-equity ratio of 0.33. The business’s 50-day moving average is $0.05 and its two-hundred day moving average is $0.04.

CV Sciences Company Profile

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.